TEMPO.CO, Jakarta – Chairman of the Indonesian Technical Advisory Group on Immunization (ITAGI) Sri Rezeki Hadinegoro said the vaccination process Covid-19 different from selling fried bananas.
“You can’t just throw it away if it’s burnt. If the vaccine (fails), not (discarded),” Sri said in a webinar, Saturday, October 31, 2020.
Sri explained that the Covid-19 vaccine candidate, which is now in the phase 3 clinical trial phase, indicates that the vaccine is safe. Because, to arrive at phase 3 clinical trials, vaccine candidates must go beyond phases 1 and 2.
Phase 1 is the stage to ensure safety. “If the phase 1 vaccine is not safe, it will not be continued,” he said.
Sri explained the purpose of giving the Covid-19 vaccine is to reduce morbidity and mortality, accelerate the achievement of herd immunity, protect and strengthen health systems, and maintain productivity and minimize social and economic impacts.
The government has collaborated on vaccines with China and the United Arab Emirates (UAE) to develop vaccines Sinovac, Cansino, and G-42 / Sinopharm. Candidates for the Covid-19 vaccine will begin entering Indonesia in early November and their procurement is coordinated by the Ministry of Health and PT Bio Farma (Persero) as an assigned SOE.
Also read: Researchers Call the Covid-19 Sinovac Vaccine Passed Phase 3 Clinical Trials
FRISKI RIANA
– .
